Matairesinol | CAS:580-72-3 | Manufacturer ChemFaces

Matairesinol

ChemFaces products have been cited in many studies from excellent and top scientific journals

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $148.1 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Isosteviol

Catalog No: CFN90544
CAS No: 27975-19-5
Price: $40/20mg

2-Hydroxynaringenin

Catalog No: CFN97950
CAS No: 58124-18-8
Price: $ / mg

Quercetin-3-o-rutinose

Catalog No: CFN92447
CAS No: 949926-49-2
Price: $ / mg

Ginsenoside Ro

Catalog No: CFN99147
CAS No: 34367-04-9
Price: $100/20mg

Reynosin

Catalog No: CFN98344
CAS No: 28254-53-7
Price: $ /

Pyrogallol

Catalog No: CFN97443
CAS No: 87-66-1
Price: $30/20mg

Eupatorin

Catalog No: CFN97418
CAS No: 855-96-9
Price: $158/10mg

Liquiritin apioside

Catalog No: CFN90707
CAS No: 74639-14-8
Price: $90/20mg

Xanthotoxin

Catalog No: CFN98372
CAS No: 298-81-7
Price: $30/20mg

3',4',5'-Trimethoxyflavone

Catalog No: CFN70439
CAS No: 67858-30-4
Price: $118/10mg

Description:

Matairesinol has radical and superoxide scavenging activities,; it also has anti-angiogenic activity by suppressing mROS signaling , can decrease hypoxia-inducible factor-1α in hypoxic HeLa cells.Matairesinol has anti-osteoporotic activity via p38/ERK-NFATc1 signaling, but not by way of anti-resorptive action. Matairesinol could markedly benefit TRAIL-based tumor therapies, including those aimed at prostate cancer.

Targets:

ROS | ATPase | p38MAPK | ERK | Akt | PI3K

In vitro:

Oncogene. 2010 Feb 11;29(6):898-908.

Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.[Pubmed: 19935713]

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to be selectively pro-apoptotic in cancer cells, with minimal toxicity to normal tissues. Although this feature makes TRAIL a promising anticancer agent, not all cancer cell types are sensitive to TRAIL-induced apoptosis despite abundant expression of TRAIL receptors. Thus, combinatorial treatments to sensitize tumor cells to TRAIL-induced apoptosis have been in the focus of extensive research. Dietary lignans have shown cancer preventive and antitumorigenic activity, but the mechanisms behind these effects are poorly known.
METHODS AND RESULTS:
Here we observed that of the three tested lignan molecules, Matairesinol (MAT) was the most effective as a death receptor-sensitizing agent. MAT sensitized the androgen-dependent LNCaP cells to TRAIL-induced apoptosis both in the presence and absence of androgens. Treatment with MAT markedly decreased Akt activity, which has been implicated as a key signaling mechanism in the TRAIL resistance of LNCaP prostate cancer cells. The involvement of the pathway in the MAT-mediated sensitization was shown in rescue experiments using ectopic expression of constitutively active Akt.
CONCLUSIONS:
Owing to the high activity of phosphatidylinositol 3-kinase/Akt signaling in cancer, targeting this survival pathway with MAT could markedly benefit TRAIL-based tumor therapies, including those aimed at prostate cancer.

Biosci Biotechnol Biochem. 2006 Aug;70(8):1934-40.

Radical and superoxide scavenging activities of matairesinol and oxidized matairesinol.[Pubmed: 16926506]

The radical and superoxide scavenging activities of oxidized Matairesinols were examined.
METHODS AND RESULTS:
It could be assumed that the free benzylic position was important for higher radical scavenging activity. The different level of activity was observed between 7'-oxoMatairesinol (Mat 2) and 7-oxoMatairesinol (Mat 3). The activity of 8-hydroxyMatairesinol was lower than that of Matairesinol (Mat 1).
CONCLUSIONS:
The superoxide scavenging activity of the oxidized Matairesinols was also demonstrated for the first time. It is assumed that the pKa value of phenol in the oxidized Matairesinols affected this activity.

In vivo:

J Ethnopharmacol . 2016 Jul 1;187:49-56.

Forsythia suspensa fruit extracts and the constituent matairesinol confer anti-allergic effects in an allergic dermatitis mouse model[Pubmed: 27085937]

Abstract Ethnopharmacological relevance: Forsythia suspensa is used in traditional medicine to treat inflammation. To clarify the anti-inflammatory and anti-allergic effects of F. suspensa fruits, we determined the therapeutic effects of crude extract, fractions, and a constituent from F. suspensa fruits on a murine atopic dermatitis (AD) model. Materials and methods: We investigated the inhibitory effects of F. suspensa extract (FSE), extract fractions, and the constituent Matairesinol on histamine release from MC/9 mast cells activated by compound 48/80 and the development of AD-like skin lesions and symptoms in NC/Nga mice exposed to Dermatophagoides farinae (mite) extract. High performance liquid chromatography (HPLC) analysis of FSE and its fractions were evaluated using Matairesinol standard. Results: FSE, FSE methylene chloride fraction (FSE-MC), and FSE water fraction (FSE-water) inhibited compound 48/80-induced histamine release from MC/9 mast cells. Topical application of FSE or FSE-MC to NC/Nga mice exposed to Dermatophagoides farinae suppressed the development of AD-like skin lesions. Quantitative HPLC analysis of FSE and FSE-MC identified the presence of Matairesinol. Topical application of Matairesinol to NC/Nga mice effectively reduced AD symptoms, inhibited inflammatory cell infiltration, and lowered immunoglobulin E levels in serum. Further study demonstrated that DfE-induced changes in IL-4 and IFN-γ mRNA expression in the ears of NC/Nga mice were reversed by Matairesinol application. Conclusions: These results indicate that the F. suspensa and its constituent Matairesinol might be a therapeutic candidate for treating allergic inflammatory disorders such as AD. Keywords: Anti-allergic; Anti-inflammatory; Forsythia suspensa; Histamine; Mast cells; Matairesinol.

Matairesinol Description

Source:	The roots of Wikstroemia indica
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Kinase Assay:

J Pharm Pharmacol. 2015 Apr 29.

Cytotoxicity of arctigenin and matairesinol against the T-cell lymphoma cell line CCRF-CEM.[Pubmed: 25922263]

Arctigenin and Matairesinol possess a diversity of bioactivities. Here we investigated the cytotoxicity of arctigenin and Matairesinol against a T-cell lymphoma cell line CCRF-CEM and the underlying mechanisms that have not been explored before.
METHODS AND RESULTS:
The cytotoxic activity was investigated using MTT assay. The cell cycle arrest and reactive oxygen species (ROS) accumulation were determined by flow cytometric analysis. The apoptosis induction was assessed using Annexin V/Propidium Iodide assay. The gene quantification analysis was measured through real-time polymerase chain reaction.
CONCLUSIONS:
Arctigenin and Matairesinol exhibited significant antiproliferative activity against CCRF-CEM cells after 72 h treatment with IC50 values of 1.21 ± 0.15 μm and 4.27 ± 0.41 μm, respectively.

Biochem Biophys Res Commun. 2012 Apr 27;421(1):76-80.

Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species.[Pubmed: 22483751]

Mitochondrial reactive oxygen species (mROS) are involved in cancer initiation and progression and function as signaling molecules in many aspects of hypoxia and growth factor-mediated signaling.
METHODS AND RESULTS:
Here we report that Matairesinol, a natural small molecule identified from the cell-based screening of 200 natural plants, suppresses mROS generation resulting in anti-angiogenic activity. A non-toxic concentration of Matairesinol inhibited the proliferation of human umbilical vein endothelial cells. The compound also suppressed in vitro angiogenesis of tube formation and chemoinvasion, as well as in vivo angiogenesis of the chorioallantoic membrane at non-toxic doses. Furthermore, Matairesinol decreased hypoxia-inducible factor-1α in hypoxic HeLa cells.
CONCLUSIONS:
These results demonstrate that Matairesinol could function as a novel angiogenesis inhibitor by suppressing mROS signaling.

Cell Research:

BMC Complement Altern Med. 2014 Jan 21;14:35.

Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis.[Pubmed: 24444335]

Matairesinol is a plant lignan present in a wide variety of foodstuffs such as seeds, vegetables and fruits. It has various biological functions including anti-angiogenic, anti-cancer and anti-fungal activities, but its anti-osteoporotic activity, if any, is unknown.
METHODS AND RESULTS:
For osteoclast differentiation, primary mouse bone marrow-derived macrophage cells (BMMs) were cultured for 4 days in the presence of RANKL and M-CSF with the vehicle (DMSO) or Matairesinol. Cell cytotoxicity was examined by CCK-8 assay. Gene expression of NFATc1, TRAP, OSCAR, v-ATPasev0d2 were observed in the presence or absence of Matairesinol (10 μM) for the indicated times. For evaluating the involvement of NFATc1 in the anti-osteoclastogenic action of Matairesinol, BMMs were infected with pMX-IRES-GFP or pMX-IRES-CA-NFATc1-GFP for 8 h with polybrene, and then infected BMMs were cultured with M-CSF and RANKL for 4 days in the presence or absence of Matairesinol (10 μM). MAPK signaling activation was examined by immunoblotting. For measuring the resorptive activity of mature osteoclasts, osteoclasts and osteoblasts were co-cultured on BioCoat Osteologic MultiTest slides, and treated with Matairesinol for 24 h. Here we show that Matairesinol dose-dependently inhibited the RANKL-induced differentiation of BMMs into osteoclasts by downregulating RANKL-induced expression and activity of NFATc1. Ectopic overexpression of NFATc1 blunted the anti-osteoclastogenic effect of Matairesinol implicating NFATc1 in the action of Matairesinol. Additionally, Matairesinol blocked the RANKL-induced activation of p38 and ERK in BMMs, but had no effect on bone resorption activity in mature osteoclasts.
CONCLUSIONS:
Taken together, our results suggest that the anti-osteoporotic activity of Matairesinol could arise from its anti-osteoclastogenic potential via p38/ERK-NFATc1 signaling, but not by way of anti-resorptive action.

Product Name	Matairesinol
Price:	$318 / 10mg
CAS No.:	580-72-3
Catalog No.:	CFN98983
Molecular Formula:	C₂₀H₂₂O₆
Molecular Weight:	358.4 g/mol
Purity:	>=98%
Type of Compound:	Lignans
Physical Desc.:	Powder
Source:	The roots of Wikstroemia indica
Solvent:	Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download:	COA MSDS SDF Manual
Similar structural:	Comparison (Web) (SDF)
Guestbook:

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Anticancer Compound Library Antioxidants Compound Library Precursors Compound Library Lignans Compound Library ROS Inhibitor Library PI3K Inhibitor Library p38MAPK Inhibitor Library ERK Inhibitor Library ATPase Inhibitor Library Akt Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	2.7902 mL	13.9509 mL	27.9018 mL	55.8036 mL	69.7545 mL
5 mM	0.558 mL	2.7902 mL	5.5804 mL	11.1607 mL	13.9509 mL
10 mM	0.279 mL	1.3951 mL	2.7902 mL	5.5804 mL	6.9754 mL
50 mM	0.0558 mL	0.279 mL	0.558 mL	1.1161 mL	1.3951 mL
100 mM	0.0279 mL	0.1395 mL	0.279 mL	0.558 mL	0.6975 mL

CFN92059	Pluviatolide	28115-68-6	356.4	C₂₀H₂₀O₆
CFN97234	Kaerophyllin	75590-33-9	368.4	C₂₁H₂₀O₆
CFN99313	Meridinol	120051-54-9	370.4	C₂₀H₁₈O₇
CFN98786	Savinin	493-95-8	352.3	C₂₀H₁₆O₆
CFN95010	Suchilactone	50816-74-5	368.4	C₂₁H₂₀O₆
CFN95008	Isonemerosin	181524-79-8	398.4	C₂₂H₂₂O₇
CFN97895	2,3-Di(3',4'-methylenedioxybenzyl)-2-buten-4-olide	137809-97-3	352.3	C₂₀H₁₆O₆
CFN99396	7-Oxohinokinin	130837-92-2	368.3	C₂₀H₁₆O₇
CFN95243	Neoarctin B	155969-67-8	742.8	C₄₂H₄₆O₁₂
CFN96251	Bis-5,5-nortrachelogenin	870480-56-1	746.8	C₄₀H₄₂O₁₄